RECURSION PHARMACEUT

RXRX
Delayed Quote. Delayed  - 06/29 04:00:00 pm
8.05USD -0.37%

Recursion Pharmaceuticals: Q1 Earnings Snapshot

05/10/2022 | 06:03pm

SALT LAKE CITY (AP) _ Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $56 million in its first quarter.

The Salt Lake City-based company said it had a loss of 33 cents per share.

The biotechnology company posted revenue of $5.3 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

© Acquiremedia 2022
Copier lien
All news about RECURSION PHARMACEUTICALS, INC.
7d ago
06/21
06/21
06/20
06/20